Trial Profile
Phase IIA Multicenter 1 Week Treatment, Randomised, Double-Blind, Placebo Controlled Study of Depelestat in Patients Suffering From Acute Respiratory Distress Syndrome
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Sep 2021
Price :
$35
*
At a glance
- Drugs Depelestat (Primary)
- Indications Respiratory distress syndrome
- Focus Adverse reactions; Therapeutic Use
- Sponsors Debiopharm
- 06 Jun 2014 New source identified and integrated (european clinical Trials Database; 2006-000756-41)
- 06 Jun 2014 New trial record